Given the critical role of survivin in maintaining neuroblastoma (NB) cells, and the lack of survivin-targeting drugs that have progressed to clinical trials for NB, we investigated the efficacy of survivin-targeting strategies in NB. The gene discussed is BIRC5; the disease is neuroblastoma.